Prostate Cancer PSA

The Prostate Specific Antigen known as PSA are protein formed by the prostate glands that is basically originated from the blood. A man suffering from a prostate cancer has a higher PSA levels compared to normal. Prostate specific antigen test was prepared to determine the height of PSA forming to blood. Using this test was permitted by FDA to distinguish the existence of this cancerous disease with the elderly men. Prostate cancer PSA testing was likewise accepted by FDA with those patients who have a prior history to be able to check the possible comeback of the disease.

When a man is suspected to have a higher level of PSA, it’s probably the cancer has occurred. Even though, there might be another reason for the rising of the PSA. A number of factors were taken to consideration by the doctors on taking the prostate cancer PSA test, blood samples can be typically taken throughout the prostate cancer PSA test and amount is can be measured in the laboratory. PSA was also named as the “tumor marker” or rather the “biological marker” for the reason that it was utilized for detection of the diseases and was created by body the cells.

» Read more: Prostate Cancer PSA

Related posts

Possible Ovarian Cancer Treatment Target Identified

“Ovarian cancer is typically diagnosed at an advanced stage when it is incurable, and the same treatments have been used for virtually all patients,” says Michael Birrer, MD, PhD, director of medical gynecologic oncology in the Massachusetts General Hospital (MGH) Cancer Center, the study’s corresponding author. “Previous research from my lab indicated that different types and grades of ovarian tumors should be treated differently, and this paper now shows that even papillary serous tumors have differences that impact patient prognosis.” Birrer was with the National Institutes of Health when this study began and joined the MGH Cancer Center.

The fifth most common malignancy among U.S. women, ovarian cancer is expected to cause close to 15,000 deaths during 2009. Accounting for 60 percent of ovarian cancers, papillary serous tumors are typically diagnosed after spreading beyond the ovaries. The tumors typically return after initial treatment with surgery and chemotherapy, but while some patients die a few months after diagnosis, others may survive five years or longer while receiving treatment.

» Read more: Possible Ovarian Cancer Treatment Target Identified

Related posts

Does Resveratrol Prevent Prostate Cancer?

Research studies concerning resveratrol and prostate cancer have been promising. Researchers believe the results warrant future investigations concerning resveratrol prostate cancer prevention and treatment.

The antioxidant appears to inhibit the growth of cancerous cells, according to studies sponsored by the National Institute of Health in the United States. In later studies concerning resveratrol and prostate cancer, researchers included other phytochemicals, which are plant components with activity similar to, but different from, those of resveratrol.

Some phytochemicals inhibit the grown of cancerous cells while others cause them to commit suicide. Living cells are amazing things. You really wouldn’t believe everything that’s going on within them every minute of every day.

» Read more: Does Resveratrol Prevent Prostate Cancer?

Related posts